{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:40:21Z","timestamp":1792658421765,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1094-8","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T15:35:07Z","timestamp":1519745707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Mitochondrial damage and \u201cplugging\u201d of transport selectively in myelinated, small-diameter axons are major early events in peripheral neuroinflammation"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4050-7477","authenticated-orcid":false,"given":"Marija","family":"Sajic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keila Kazue","family":"Ida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Canning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman A.","family":"Gregson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Duchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"key":"1094_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1212\/01.WNL.0000149521.65474.83","volume":"64","author":"C de la Dornonville Cour","year":"2005","unstructured":"de la Dornonville Cour C, Jakobsen J. Residual neuropathy in long-term population-based follow-up of Guillain-Barr\u00e9 syndrome. Neurology. 2005;64:246\u201353.","journal-title":"Neurology"},{"key":"1094_CR2","doi-asserted-by":"publisher","unstructured":"Karkare K, Taly AB, Sinha S, Rao S. Temporal profile of pain and other sensory manifestations in Guillain-Barr\u00e9 syndrome during ten days of hospitalization. Neurol India. 2011;59(5):712\u20136. https:\/\/doi.org\/10.4103\/0028-3886.86546 .","DOI":"10.4103\/0028-3886.86546"},{"key":"1094_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/mus.24887","volume":"52","author":"BR Wakerley","year":"2015","unstructured":"Wakerley BR, Yuki N. Isolated facial diplegia in Guillain-Barr\u00e9 syndrome: bifacial weakness with paresthesias. Muscle Nerve. 2015;52:927\u201332.","journal-title":"Muscle Nerve"},{"key":"1094_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2169\/internalmedicine.54.2972","volume":"54","author":"R Hayashi","year":"2015","unstructured":"Hayashi R, Yamaguchi S. Guillain-Barr\u00e9 syndrome variant with facial diplegia and paresthesias associated with IgM anti-GalNAc-GD1a antibodies. Intern Med. 2015;54:345\u20137.","journal-title":"Intern Med"},{"key":"1094_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.survophthal.2011.10.002","volume":"57","author":"D Biotti","year":"2012","unstructured":"Biotti D, et al. Blindness, weakness, and tingling. Surv Ophthalmol. 2012;57:565\u201372.","journal-title":"Surv Ophthalmol"},{"key":"1094_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1212\/WNL.48.2.328","volume":"48","author":"DE Moulin","year":"1997","unstructured":"Moulin DE, Hagen N, Feasby TE, Amireh R, Hahn A. Pain in Guillain-Barr\u00e9 syndrome [see comments]. Neurology. 1997;48:328\u201331.","journal-title":"Neurology"},{"key":"1094_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pain.2010.05.017","volume":"151","author":"V Martinez","year":"2010","unstructured":"Martinez V, et al. Small fibre impairment predicts neuropathic pain in Guillain-Barr\u00e9 syndrome. Pain. 2010;151:53\u201360.","journal-title":"Pain"},{"key":"1094_CR8","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","volume":"75","author":"L Ruts","year":"2010","unstructured":"Ruts L, et al. Pain in Guillain-Barr\u00e9 syndrome: a long-term follow-up study. Neurology. 2010;75:1439\u201347.","journal-title":"Neurology"},{"key":"1094_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jns.2006.12.012","volume":"254","author":"S Boukhris","year":"2007","unstructured":"Boukhris S, Magy L, Khalil M, Sindou P, Vallat JM. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). J Neurol Sci. 2007;254:33\u20138.","journal-title":"J Neurol Sci"},{"key":"1094_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00415-009-0018-z","volume":"256","author":"T Rekand","year":"2009","unstructured":"Rekand T, Gramstad A, Vedeler CA. Fatigue, pain and muscle weakness are frequent after Guillain-Barr\u00e9 syndrome and poliomyelitis. J Neurol. 2009;256:349\u201354.","journal-title":"J Neurol"},{"key":"1094_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2004.09.021","volume":"227","author":"A Forsberg","year":"2004","unstructured":"Forsberg A, et al. Impairment in Guillain\u2013Barr\u00e9 syndrome during the first 2 years after onset: a prospective study. J Neurol Sci. 2004;227:131\u20138.","journal-title":"J Neurol Sci"},{"key":"1094_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s004150170157","volume":"248","author":"RA Bernsen","year":"2001","unstructured":"Bernsen RA, Jager AE, Schmitz PI, van der Mech\u00e9 FG. Long-term sensory deficit after Guillain-Barr\u00e9 syndrome. J Neurol. 2001;248:483\u20136.","journal-title":"J Neurol"},{"key":"1094_CR13","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1038\/sj.emboj.7601253","volume":"25","author":"MJ Barsoum","year":"2006","unstructured":"Barsoum MJ, et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 2006;25:3900\u201311.","journal-title":"EMBO J"},{"key":"1094_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1126\/science.1171091","volume":"324","author":"D-H Cho","year":"2009","unstructured":"Cho D-H, et al. S-Nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science. 2009;324:102\u20135.","journal-title":"Science"},{"key":"1094_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ceb.2003.10.015","volume":"15","author":"E Bossy-Wetzel","year":"2003","unstructured":"Bossy-Wetzel E, Barsoum MJ, Godzik A, Schwarzenbacher R, Lipton SA. Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr Opin Cell Biol. 2003;15:706\u201316.","journal-title":"Curr Opin Cell Biol"},{"key":"1094_CR16","doi-asserted-by":"publisher","first-page":"C157","DOI":"10.1152\/ajpcell.00272.2006","volume":"292","author":"A Kaasik","year":"2006","unstructured":"Kaasik A, Safiulina D, Zharkovsky A, Veksler V. Regulation of mitochondrial matrix volume. AJP Cell Physiol. 2006;292:C157\u201363.","journal-title":"AJP Cell Physiol"},{"key":"1094_CR17","doi-asserted-by":"crossref","unstructured":"Sadeghian M, et al. Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis. Sci Rep. 2016;6(1):33249.","DOI":"10.1038\/srep33249"},{"key":"1094_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nm.2324","volume":"17","author":"I Niki\u0107","year":"2011","unstructured":"Niki\u0107 I, et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med. 2011;17:495\u20139.","journal-title":"Nat Med"},{"key":"1094_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-510X(00)00343-9","volume":"177","author":"F Lu","year":"2000","unstructured":"Lu F, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci. 2000;177:95\u2013103.","journal-title":"J Neurol Sci"},{"key":"1094_CR20","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/brain\/awp046","volume":"132","author":"DJ Mahad","year":"2009","unstructured":"Mahad DJ, et al. Mitochondrial changes within axons in multiple sclerosis. Brain. 2009;132:1161\u201374.","journal-title":"Brain"},{"key":"1094_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbabio.2009.02.021","volume":"1787","author":"F Celsi","year":"2009","unstructured":"Celsi F, et al. Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim Biophys Acta Bioenerg. 2009;1787:335\u201344.","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"1094_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.phrs.2015.05.007","volume":"99","author":"R Abeti","year":"2015","unstructured":"Abeti R, Abramov AY. Mitochondrial Ca2+ in neurodegenerative disorders. Pharmacol Res. 2015;99:377\u201381.","journal-title":"Pharmacol Res"},{"key":"1094_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2174\/1570159X13666150703154541","volume":"14","author":"S Arun","year":"2016","unstructured":"Arun S, Liu L, Donmez G. Mitochondrial biology and neurological diseases. Curr Neuropharmacol. 2016;14:143\u201354.","journal-title":"Curr Neuropharmacol"},{"key":"1094_CR24","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1529\/biophysj.106.092981","volume":"92","author":"SL Mironov","year":"2007","unstructured":"Mironov SL. ADP regulates movements of mitochondria in neurons. Biophys J. 2007;92:2944\u201352.","journal-title":"Biophys J"},{"key":"1094_CR25","doi-asserted-by":"publisher","first-page":"20728","DOI":"10.1073\/pnas.0808953105","volume":"105","author":"M Saotome","year":"2008","unstructured":"Saotome M, et al. Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci U S A. 2008;105:20728\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1094_CR26","doi-asserted-by":"publisher","first-page":"e1001754","DOI":"10.1371\/journal.pbio.1001754","volume":"11","author":"M Sajic","year":"2013","unstructured":"Sajic M, et al. Impulse conduction increases mitochondrial transport in adult mammalian peripheral nerves in vivo. PLoS Biol. 2013;11:e1001754.","journal-title":"PLoS Biol"},{"key":"1094_CR27","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1242\/jcs.053850","volume":"125","author":"WM Saxton","year":"2012","unstructured":"Saxton WM, Hollenbeck PJ. The axonal transport of mitochondria. JCell Sci. 2012;125:2095\u2013104.","journal-title":"JCell Sci"},{"key":"1094_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.celrep.2016.09.004","volume":"17","author":"G L\u00f3pez-Dom\u00e9nech","year":"2016","unstructured":"L\u00f3pez-Dom\u00e9nech G, et al. Loss of dendritic complexity precedes neurodegeneration in a mouse model with disrupted mitochondrial distribution in mature dendrites. Cell Rep. 2016;17:317\u201327.","journal-title":"Cell Rep"},{"key":"1094_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1083\/jcb.201106120","volume":"196","author":"S Maday","year":"2012","unstructured":"Maday S, Wallace KE, Holzbaur ELF. Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J Cell Biol. 2012;196:407\u201317.","journal-title":"J Cell Biol"},{"key":"1094_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1083\/jcb.201401070","volume":"206","author":"G Ashrafi","year":"2014","unstructured":"Ashrafi G, Schlehe JS, LaVoie MJ, Schwarz TL. Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J Cell Biol. 2014;206:655\u201370.","journal-title":"J Cell Biol"},{"key":"1094_CR31","doi-asserted-by":"publisher","first-page":"a011304","DOI":"10.1101\/cshperspect.a011304","volume":"5","author":"TL Schwarz","year":"2013","unstructured":"Schwarz TL. Mitochondrial trafficking in neurons. Cold Spring Harb Perspect Biol. 2013;5:a011304.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1094_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2011.10.018","volume":"147","author":"X Wang","year":"2011","unstructured":"Wang X, et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell. 2011;147:893\u2013906.","journal-title":"Cell"},{"key":"1094_CR33","doi-asserted-by":"crossref","first-page":"9046","DOI":"10.1523\/JNEUROSCI.23-27-09046.2003","volume":"23","author":"OI Wagner","year":"2003","unstructured":"Wagner OI, et al. Mechanisms of mitochondria-neurofilament interactions. J Neurosci. 2003;23:9046\u201358.","journal-title":"J Neurosci"},{"key":"1094_CR34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.pain.2011.10.037","volume":"153","author":"L Ruts","year":"2012","unstructured":"Ruts L, et al. Unmyelinated and myelinated skin nerve damage in Guillain-Barr\u00e9 syndrome: correlation with pain and recovery. Pain. 2012;153:399\u2013409.","journal-title":"Pain"},{"key":"1094_CR35","doi-asserted-by":"crossref","unstructured":"Rolyan H, et al. A painful neuropathy-associated Nav1.7 mutant leads to time-dependent degeneration of small-diameter axons associated with intracellular Ca2+ dysregulation and decrease in ATP levels. Mol Pain. 2016;12:1\u201313.","DOI":"10.1177\/1744806916674472"},{"key":"1094_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/brain\/awh118","volume":"127","author":"GC DeLuca","year":"2004","unstructured":"DeLuca GC, Ebers GC, Esiri MM. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain. 2004;127:1009\u201318.","journal-title":"Brain"},{"key":"1094_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1212\/WNL.60.1.108","volume":"60","author":"CJ Sumner","year":"2003","unstructured":"Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology. 2003;60:108\u201311.","journal-title":"Neurology"},{"key":"1094_CR38","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye S, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285\u201393.","journal-title":"Diabetes Care"},{"key":"1094_CR39","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1212\/WNL.57.9.1701","volume":"57","author":"AG Smith","year":"2001","unstructured":"Smith AG, Ramachandran P, Tripp S, Singleton JR. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology. 2001;57:1701\u20134.","journal-title":"Neurology"},{"key":"1094_CR40","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/WCO.0b013e3282f1a06e","volume":"20","author":"G Kannarkat","year":"2007","unstructured":"Kannarkat G, Lasher EE, Schiff D. Neurologic complications of chemotherapy agents. Curr Opin Neurol. 2007;20:719\u201325.","journal-title":"Curr Opin Neurol"},{"key":"1094_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1212\/WNL.58.1.115","volume":"58","author":"M Polydefkis","year":"2002","unstructured":"Polydefkis M, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology. 2002;58:115\u20139.","journal-title":"Neurology"},{"key":"1094_CR42","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/brain\/awl010","volume":"129","author":"M-T Tseng","year":"2006","unstructured":"Tseng M-T, et al. Skin denervation and cutaneous vasculitis in systemic lupus erythematosus. Brain. 2006;129:977\u201385.","journal-title":"Brain"},{"key":"1094_CR43","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1212\/01.wnl.0000266668.03638.94","volume":"69","author":"Y Oki","year":"2007","unstructured":"Oki Y, et al. Ataxic vs painful form of paraneoplastic neuropathy. Neurology. 2007;69:564\u201372.","journal-title":"Neurology"},{"key":"1094_CR44","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/S0140-6736(02)08912-2","volume":"359","author":"E Hoitsma","year":"2002","unstructured":"Hoitsma E, et al. Small fibre neuropathy in sarcoidosis. Lancet. 2002;359:2085\u20136.","journal-title":"Lancet"},{"key":"1094_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10072-010-0475-2","volume":"32","author":"MP Giannoccaro","year":"2011","unstructured":"Giannoccaro MP, et al. Somatic and autonomic small fiber neuropathy induced by bortezomib therapy: an immunofluorescence study. Neurol Sci. 2011;32:361\u20133.","journal-title":"Neurol Sci"},{"key":"1094_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1529-8027.2008.00173.x","volume":"13","author":"JG Heckmann","year":"2008","unstructured":"Heckmann JG, D\u00fctsch M, Schwab S. Linezolid-associated small-fiber neuropathy. J Peripher Nerv Syst. 2008;13:157\u20138.","journal-title":"J Peripher Nerv Syst"},{"key":"1094_CR47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/mus.22239","volume":"45","author":"AZ Burakgazi","year":"2012","unstructured":"Burakgazi AZ, Polydefkis M, H\u00f6ke A. Skin biopsy-proven flecainide-induced neuropathy. Muscle Nerve. 2012;45:144\u20136.","journal-title":"Muscle Nerve"},{"key":"1094_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0165-5728(83)90036-X","volume":"4","author":"U Traugott","year":"1983","unstructured":"Traugott U, Reinherz EL, Raine CS. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol. 1983;4:201\u201321.","journal-title":"J Neuroimmunol"},{"key":"1094_CR49","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plant\u00e9-Bordeneuve","year":"2011","unstructured":"Plant\u00e9-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011;10:1086\u201397.","journal-title":"Lancet Neurol"},{"key":"1094_CR50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jneumeth.2010.09.007","volume":"193","author":"S Andrews","year":"2010","unstructured":"Andrews S, Gilley J, Coleman MP. Difference tracker: ImageJ plugins for fully automated analysis of multiple axonal transport parameters. J Neurosci Methods. 2010;193:281\u20137.","journal-title":"J Neurosci Methods"},{"key":"1094_CR51","doi-asserted-by":"crossref","unstructured":"Gilley J, et al. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a \u2018P301L\u2019 tau knockin mouse. Neurobiol Aging. 2012;33(3):621. e1\u2013621.e15.","DOI":"10.1016\/j.neurobiolaging.2011.02.014"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1094-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T23:31:33Z","timestamp":1660519893000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1094-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1094-8","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"15 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were carried out according to the 1986 Animals (Scientific Procedures) Act, UK, and were approved by the institutional ethics committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"61"}}